Symed Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is PRUCALOPRIDE SUCCINATE, with a corresponding US DMF Number 34862.
Remarkably, this DMF maintains an Active status since its submission on September 25, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 12, 2023, and payment made on July 26, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II